Shares of Beam Therapeutics Inc. (BEAM) climbs 29% on Tuesday after the company reported fourth-quarter earnings and revenue that beat the Street estimates.
BEAM is trading on the Nasdaq at $46.28, up 29.27% or $10.48 per share. It has traded between $16.95 and $49.50 in the past 52-week period.
The company reported a net income of $142.8 million or $1.73 per share for the quarter, compared to the loss of $36.1 million or $0.54 per share the prior year.
Analysts on average had expected a loss of $1.01 per share, according to figures compiled by Thomson Reuters.
Revenue increased to $316.2 million from $20.0 million the previous year. It beat the consensus estimate of $18.67 million.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.